bw 301u isethionate

Piritrexim isethionate is a lipid-soluble inhibitor of dihydrofolate reductase (DHFR) that appears to be an active agent in patients with metastatic urothelial cancer when administered as a 5-day, low-dose oral schedule.

Piritrexim (BW 301U) 是一种可口服的脂溶性二氢叶酸还原酶抑制剂，具有肺毒性，用于研究尿路上皮癌和转移性乳腺癌。